Cell Cryopreservation Market Analysis

Cell Cryopreservation Market Analysis

To get key market trends

  Download Free Sample

The market by product type is categorized into cryoprotectant agents and equipment. The equipment into garnered USD 7.5 billion revenue size in the year 2023. The equipment segment is further segmented freezers, incubators, liquid nitrogen supply tanks and cryopreservation consumables. Concurrently, there is a notable trend towards automation in cryopreservation equipment.

• Automated systems are gaining prominence for their ability to streamline workflows, minimize manual errors, and significantly enhance the overall efficiency of processes related to cell banking and storage.

   

• As a result, there is a rising demand for cryopreservation equipment equipped with integrated automation features. This shift underscores the industry's commitment to adopting cutting-edge technologies that not only meet the demands of biobanking but also contribute to the advancement of cryopreservation practices.

   

• The rise in biobanking activities, driven by increased demand for high-quality biological samples, directly impacts the demand for biomedical refrigerators and freezers. Biobanks utilize specialized equipment for the preservation and storage of diverse biological materials.

Based on cell type, the cell cryopreservation market unfolds its segmentation, such as stem cells, oocytes and embryotic cells, sperm cells, hepatocytes, and other cell types. The stem cells segment garnered USD 4 billion revenue size in the year 2023. Moreover, the therapeutic potential of stem cells is broad and continues to expand, contributing significantly to the growth of the stem cells segment.

• The development of induced pluripotent stem cells (iPSCs) has been a groundbreaking advancement. iPSCs are adult cells that have been reprogrammed to have embryonic stem cell-like properties, providing a valuable source of patient-specific cells for regenerative therapies.

   

• Stem cells, particularly neural stem cells and iPSCs, are being investigated for their potential in treating neurological conditions. This includes disorders like Parkinson's disease, Alzheimer's disease, and spinal cord injuries, where the goal is to replace damaged or lost neurons.

   

• The integration of gene editing techniques, such as CRISPR-Cas9, has revolutionized the field of stem cell research. This allows scientists to precisely modify the genetic makeup of stem cells, addressing specific genetic disorders or enhancing their therapeutic potential.

Based on application, the cell cryopreservation market is segmented into drug discovery and development, regenerative medicine, organ transplantation, clinical research, other applications. The drug discovery and development segment garnered USD 2.6 billion revenue size in the year 2023.

• The use of cryopreserved cell lines has become a common practice in drug discovery. Cryopreserved cells provide a stable and consistent supply of cells for high-throughput screening and other assays, ensuring reproducibility and reliability in the drug development process.

   

• Cryopreservation plays a crucial role in the development of personalized medicine. Patient-derived cells, including stem cells, can be cryopreserved for use in developing therapies tailored to individual patients. This approach is particularly relevant in oncology and other fields where personalized treatments are gaining traction.

   

• Cryopreserved cells are extensively used in preclinical studies to assess the safety and efficacy of drug candidates. The ability to cryopreserve cells ensures that researchers have a renewable source of cells for repeated experiments and long-term studies.

Based on end-use, the cell cryopreservation market unfolds its segmentation, encompassing the domains of hospitals and clinics, biotechnology and pharmaceutical companies, research and academic institutes, contract research organizations (CROs), which is estimated to account for USD 56.7 billion in 2022. The biotechnology and pharmaceutical companies segment garnered USD 3.4 billion revenue size in the year 2023.

• Biotechnology and pharmaceutical companies often work with specific cell lines, cultures, and primary cells for various purposes, including drug development, manufacturing, and research. Cryopreservation allows them to preserve these valuable biological materials for future use, ensuring a stable and consistent supply.

   

• They are engaged in long-term projects that require the storage of cells over extended periods. Cryopreservation allows for the long-term preservation of cells, ensuring their viability and functionality when retrieved for experiments, clinical trials, or production.

   

• In bioprocessing and manufacturing, cryopreserved cells are essential for producing biopharmaceuticals, vaccines, and other bio-based products. Cryopreservation ensures that cell lines used in large-scale production remain stable and maintain desired characteristics over time.

U.S. cell cryopreservation market accounted for USD 4.3 billion revenue size in 2023 and is predicted to witness substantial market growth over the analysis timeline.

• The U.S. is a global hub for biotechnology and pharmaceutical research and development. The presence of numerous biotech and pharmaceutical companies, research institutions, and academic centers conducting cutting-edge research contributes to the high demand for cell cryopreservation services and technologies.

   

• The U.S. is a leader in conducting clinical trials and drug development activities. Cell cryopreservation is crucial in these endeavors, facilitating the storage of cells for preclinical studies, clinical trials, and the development of cell-based therapies.

   

• Thus, the country's strong emphasis on research and development, coupled with a high prevalence of chronic disease, fuels continuous advancements and widespread use of these equipment’s.